title: Hypothyroidism and goitre during interleukin-2 therapy without LAK cells.
authors.forename: P A
authors.initials: PA
authors.lastname: van Liessum
authors.forename: P H
authors.initials: PH
authors.lastname: de Mulder
authors.forename: E J
authors.initials: EJ
authors.lastname: Mattijssen
authors.forename: F H
authors.initials: FH
authors.lastname: Corstens
authors.forename: D J
authors.initials: DJ
authors.lastname: Wagener
mesh_terms: D005260:Female; D006042:Goiter / Q000139:chemically induced*; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D007376:Interleukin-2 / Q000009:adverse effects*; D007694:Killer Cells, Natural; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins